The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...
Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
Hive Autonomy, a Norwegian leader in autonomous technology, has become the factory’s first customer, using Telenor’s ...
By Bertus Bierman South Africa faces immense challenges in developing and maintaining the infrastructure it needs to support ...
Stephen Miller at the border. Matt Gaetz running the DOJ. A Fox News host as Secretary of Defense. Welcome to the Trump ...
but also what knock-on implications this may have on the wider environment because bees play such a key role as a pollinator.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback